SEC Form 4 · accession 0001179110-15-001804
ABIOMED INC · ABMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William J Bolt
Officer — SVP, QA and Regulatory Affairs
Period of report
Feb 2, 2015
Accepted (ET)
Feb 4, 2015 · 4:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000815094
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $.01 par | Feb 2, 2015 | M | 8,000 | $11.27 | A | 89,228 | D | |
| Common Stock, $.01 par | Feb 2, 2015 | M | 20,000 | $13.57 | A | 109,228 | D | |
| Common Stock, $.01 parF6 | Feb 2, 2015 | S | 28,000 | $51.4122 | D | 81,228 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $13.57 | Feb 2, 2015 | M | 20,000 | D | Jun 1, 2007 | Jun 1, 2016 | Common Stock | 20,000 | 0 | D |
| Stock Option (right to buy)F1 | $11.27 | Feb 2, 2015 | M | 8,000 | D | May 30, 2008 | May 30, 2017 | Common Stock | 8,000 | 0 | D |
| Stock option (right to buy)F3,F2 | $13.80 | holding | — | — | — | May 23, 2009 | May 23, 2018 | Common Stock | 0 | 9,666 | D |
| Stock Option (right to buy)F3,F2 | $10.03 | holding | — | — | — | Jun 3, 2011 | Jun 3, 2020 | Common Stock | 0 | 25,000 | D |
| Stock Option (right to buy)F3,F2 | $22.44 | holding | — | — | — | May 22, 2013 | May 22, 2022 | Common Stock | 0 | 20,000 | D |
| Stock Option (Right to Buy)F3,F2 | $23.15 | holding | — | — | — | May 14, 2014 | May 14, 2023 | Common stock | 0 | 20,000 | D |
| Stock Option (Right to Buy)F3,F4 | $21.55 | holding | — | — | — | May 14, 2015 | May 14, 2024 | Common Stock | 0 | 15,000 | D |
Explanation of responses
- F1Grant to reporting person of this option to buy the number of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2000 Stock Incentive Plan.
- F2These options become exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
- F3Grant to reporting person of this option to buy the number of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- F4These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
- F5Sale of Common Stock pursuant to reporting owner's 10b5-1 plan.
- F6This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $50.9000 and $51.7800. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.